CR Double-Crane(SH:600062)2020-10-29 16:00Financial Performance - Net profit attributable to shareholders was CNY 873,321,158.06, representing a decrease of 4.93% year-on-year[8] - Operating revenue for the first nine months was CNY 6,373,707,849.70, down 13.95% from the same period last year[8] - The net cash flow from operating activities was CNY 1,034,488,891.56, a decline of 16.33% compared to the previous year[8] - The company's weighted average return on equity decreased by 1.43 percentage points to 9.81%[8] - Total operating revenue for Q3 2020 was CNY 2,226,591,305.51, a decrease of 12.4% compared to CNY 2,541,179,943.22 in Q3 2019[29] - The net profit for Q3 2020 was CNY 321.46 million, representing an increase of 13.14% from CNY 284.12 million in Q3 2019[31] - The total profit for Q3 2020 was CNY 382.81 million, up from CNY 336.13 million in Q3 2019, marking an increase of 13.87%[30] - The company's operating profit for the first three quarters of 2020 was CNY 1.06 billion, a decrease of 3.49% from CNY 1.10 billion in the same period of 2019[30] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 12,012,006,975.26, an increase of 6.52% compared to the end of the previous year[8] - The total amount of entrusted financial management reached CNY 2,100,000,000.00 during the reporting period[19] - Current liabilities totaled CNY 2,530,551,736.04, up from CNY 2,341,453,433.31, indicating an increase of 8.1%[25] - The company's total equity reached CNY 9,241,405,874.78, an increase from CNY 8,676,558,852.08, marking a growth of 6.5%[25] - The company's long-term liabilities decreased to CNY 240,049,364.44 from CNY 258,852,476.46, a decline of 7.3%[25] - Total liabilities increased to CNY 2,770,601,100.48, compared to CNY 2,600,305,909.77, representing a growth of 6.5%[25] Cash Flow - Cash received from tax refunds increased by ¥1,159,773.68, a growth of 134.95%, reflecting higher tax refunds this period[15] - The total cash inflow from operating activities for the first three quarters of 2020 was approximately ¥6.18 billion, down from ¥7.14 billion in the same period of 2019, indicating a decrease of 13.4%[34] - The net cash flow from operating activities for the first three quarters of 2020 was approximately ¥1.03 billion, compared to ¥1.24 billion in the same period of 2019, a decrease of 16.3%[34] - The cash outflow from investment activities for the first three quarters of 2020 was approximately ¥1.46 billion, down from ¥1.98 billion in the same period of 2019, a decrease of 26.2%[35] - The net cash flow from investment activities for the first three quarters of 2020 was approximately -¥279.45 million, compared to -¥87.80 million in the same period of 2019, indicating a worsening of 217.5%[35] - The net cash flow from financing activities for the first three quarters of 2020 was approximately -¥338.35 million, compared to -¥520.22 million in the same period of 2019, showing an improvement of 35%[35] Research and Development - R&D expenses increased by ¥41,654,640.44, a growth of 33.71%, due to increased investment in drug development and related materials and labor[14] - Research and development expenses in Q3 2020 amounted to CNY 55,194,353.74, up 40.6% from CNY 39,273,679.84 in Q3 2019[29] - The company's R&D expenses in Q3 2020 were CNY 34.06 million, an increase of 84.51% compared to CNY 18.46 million in Q3 2019[32] Investments - Investment properties increased by 70.20% to CNY 17,953,091.27, mainly due to the conversion of headquarters factory rentals[13] - The company increased its construction in progress by 43.35% to CNY 105,868,122.41, driven by projects in Henan and Anhui provinces[13] - Other non-current assets rose by 129.95% to CNY 22,741,873.91, reflecting increased investment in engineering projects[13] - Investment income decreased by ¥6,198,977.18, a decline of 75.14%, due to reduced financial investments[14] Other Financial Metrics - The company's goodwill remained stable at CNY 839,833,385.73, unchanged from the previous year[24] - The gross profit margin for Q3 2020 was approximately 63.16%, down from 61.83% in Q3 2019[32] - The basic earnings per share for Q3 2020 were CNY 0.3059, compared to CNY 0.2685 in Q3 2019, reflecting a growth of 13.06%[31] - The company plans to continue expanding its market presence and investing in new product development to drive future growth[29]